Merz to complete Acquisition of BioForm Medical (19 Feb 2010)
Merz Pharma Group successfully completes BioForm Medical Tender offer with over 94 Percent of shares tendered (16 Feb 2010)
Merz and Acumen partner in innovative Alzheimer’s approach (12 Jan 2010)
Merz to acquire BioForm Medical (04 Jan 2010)
Successful fiscal year for the Merz Pharma Group (18 Nov 2009)
Merz Pharmaceuticals and Kyorin Pharmaceutical Co., Ltd. enter into Neramexane Partnership for Japanese Tinnitus Market (05 Nov 2009)
Alzheimer drug memantine must remain available to all patients in Germany (17 Sep 2009)
Professor Richard Gallo awarded 19th annual Friedrich Merz Guest Professorship / high-caliber symposium held in Frankfurt (17 Jun 2009)
Changes in the Merz Group Management (02 Jul 2008)
The pharmaceutical company Merz is 100 years old (07 Mar 2008)
Professor Josef Rauschecker appointed as 18th annual Friedrich Merz Guest Professorship / Prestigious Symposium in Frankfurt (26 Feb 2008)
Merz Group experiences successful 2006/07 financial year (20 Nov 2007)
The Expansion Continues: Merz Invests an Additional Million Euro Sum in Dessau (26 Jul 2007)
Recommendation of Approval for the Merz Botulinum Neurotoxin Typ A in European Countries (20 Jul 2007)
Merz Pharmaceuticals and Tel Aviv University Become Partners in Novel Drug Technology Development for Treatment of Alzheimer's (10 Jul 2007)
Merz funded Alois Alzheimer Award 2007 bestowed upon Professor Dr. Agneta Nordberg (15 Jun 2007)
Alzheimer's medication Memantine exceeds blockbuster mark of 1 billion US dollars (15 May 2007)
"Change in Merz Group leadership: Professor Scheuble will be leaving the company (23 Apr 2007)
Frankfurt Biotechnology Innovation Center plans large expansion with Merz Pharma (01 Feb 2007)
![back to top [link]](skin_img/skin_contentSiteInfo-backToTop-arrow.gif)
Last update: 21 Apr 2010, 10:55
produced by GPM mbH
URL: http://www.merz.com/press/press-releases/company
Last update: 21.04.2010, 10:55 Uhr
© 2010 Merz. All rights reserved.